Live Breaking News & Updates on Tsutomu Takeuchi

Stay updated with breaking news from Tsutomu takeuchi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Infliximab Biosimilar CT-P13 Provides Consistent Safety, Efficacy Across 4 Diseases

A review of Japan post-marketing data support the biosimilar in use for psoriasis, rheumatoid arthritis, Crohn's disease and ulcerative colitis. ....

Tsutomu Takeuchi , European Union , Keio University School Of Medicine , Keio University School ,

Ozoralizumab exhibits long half-life, favorable pharmokinetics in rheumatoid arthritis

Ozoralizumab demonstrates a long half-life and favorable pharmacokinetics, as well as sustained efficacy, over 52 weeks in patients with rheumatoid arthritis, according to data published in Arthritis Research & Therapy. ....

Tsutomu Takeuchi , Nanobody Vhhs , Arthritis Research Therapy , Keio University School Of Medicine , Arthritis Research , Keio University School ,